Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma

Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma

Autor Morena, Ana Maria Lira Autor UNIFESP Google Scholar
Oshima, Celina Tizuko Fujiyama Autor UNIFESP Google Scholar
Gebrim, Luiz Henrique Autor UNIFESP Google Scholar
Egami, Mizue Imoto Autor UNIFESP Google Scholar
Silva, Maria Regina Regis da Autor UNIFESP Google Scholar
Segreto, Roberto Araujo Autor UNIFESP Google Scholar
Giannotti Filho, Osvaldo Autor UNIFESP Google Scholar
Teixeira, Vicente de Paulo Castro Autor UNIFESP Google Scholar
Segreto, Helena Regina Comodo Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Oncoctr Fdn Sao Paulo
Resumo The purpose of the present study was to evaluate breast carcinoma samples before and two days after treatment with tamoxifen in order to analyse early histopathological alterations - particularly nuclear alterations - as well as immunohistochemical expression of Ki-67, Erb-B2, VEGF, TGf-beta 1 and ILK proteins. Twenty one cases of invasive ductal and lobular breast carcinoma were studied. Patients were submitted to biopsy of the lesion and, after confirmation of the diagnosis, they received 20 mg of tamoxifen a day, beginning two days before surgery. The samples obtained during biopsy and after surgery were stained with HE for histopathological diagnosis. Estrogen receptor was positive in IS cases and negative in 3. The immunohistochemical method was applied for the detection of Ki-67, Erb-B2, protein, vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta 1) and integrin linked kinase (ILK).Two days after tamoxifen treatment, the following results were observed: 1) decrease in the cell volume, chomatine condensation, nucleoli less evident and clearly defined nuclear limits; 2) significant reduction in the expression of Erb-B2 protein and significant increase in the expression of TGF-beta 1 protein; 3) expression of others proteins (Ki-67, VEGF and ILK) was not altered during the indicated time frame.Our results suggest that analyzing nuclear alterations and expression of Erb-B2 and TGF-beta 1 proteins would be useful to assess the initial response to tamoxifen.
Assunto breast cancer
tamoxifen
immunohistochemistry
tumor markers
Erb-B2
TGF-beta 1
Idioma Inglês
Data 2004-01-01
Publicado em Neoplasma. Brastislava: Veda, Slovak Academy Sciences, v. 51, n. 6, p. 481-486, 2004.
ISSN 0028-2685 (Sherpa/Romeo, fator de impacto)
Editor Veda, Slovak Academy Sciences
Extensão 481-486
Fonte http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage-ask.tpl&product_id=846&category_id=32&option=com_virtuemart&Itemid=11&vmcchk=1&Itemid=11
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000226042900012
URI http://repositorio.unifesp.br/11600/44983

Mostrar registro completo




Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)